ArticleACS omega2025
Detailed Physicochemical Analysis of Hyaluronic Acid and Transferrin Self-Assembly To Produce Drug Carrier Colloids.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyelectrolyte complexes (PECs) are polymeric nanostructures created by the self-assembly of oppositely charged macromolecules. PEC-based novel biomaterials are currently being researched as controlled drug delivery vehicles due to their unique combination of beneficial properties. In this work, the formation of a new colloid system composed of human apo-transferrin (Tr) protein and high-molecular-weight hyaluronic acid (HyA) polysaccharide was studied from numerous perspectives because, to the best of our knowledge, no information is available regarding this PEC-based Tr-HyA formula. For detailed characterization, the experimental results of several physicochemical and colloid chemistry techniques, such as light scattering, rheology, titration microcalorimetry, and electron microscopy, were analyzed. It was emphasized that the pH and mass ratio of the macromolecules greatly influence the self-assembly process. Particles with enhanced stability were prepared at a Tr/HyA = 2:1 mass ratio. The applicability of these colloid particles with a diameter of 240-260 nm as drug delivery vehicles was evaluated by encapsulating several practically water-insoluble molecules to increase their solubility in water. We highlighted that the nanoformulation revealed ca. 3 times better solubility and enhanced release for vitamins D3 and K1 compared to the unformulated ones.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.